OBJECTIVES: Describe primary care physicians' decision to prescribe antidepressants to older patients with depression. METHODS: Electronic medical record notes from offi ce visits of older patients (age 65), treated in a multi-specialty medical group practice located in central Massachusetts, were screened bi-weekly for mention of depression from August 2007 to July 2008. Electronic surveys inquiring about depression severity and onset, and antidepressant treatment recommendations were sent to treating physicians until a target sample of approximately 400 responses was reached. Patient characteristics and treatment were identifi ed from administrative claims. Univariate analyses were used to describe patient characteristics and physician survey responses. RESULTS: The majority of the 396 patients whose physicians responded to the survey and confi rmed depression were female (76.5%), on average 77 years old; 66.7% had age 65-80 years. Most patients had physician-reported depression onset after age 60 (72.2%) and moderately severe depression (58.8%). Physicians reported that 62.9% of patients were already treated with antidepressants at time of screening, 28.5% were recommended antidepressant initiation, and 8.6% were not prescribed antidepressants; the rate of patients who were not prescribed antidepressants was similar in patients age 65-80 and over 80 years. SSRIs were most frequently prescribed. Maintaining prior therapy was recommended for 81.1% of patients and treatment modifi cation for 18.9%. Almost all physicians agreed that experience in use of drugs, safety/tolerability, and patient improvement infl uenced their choice to maintain prior therapy or recommend new therapy ( 92%). 85.8% of physicians agreed that availability of effi cacy data in the elderly infl uenced their decision to prescribe new therapy. A total of 38.9% of patients recommended new therapy initiation did not fi ll a prescription. CONCLUSIONS: The majority of older patients with depression are prescribed antidepressants, mostly receiving a recommendation to maintain prior therapy. Over two thirds of patients who were recommended new antidepressant therapy did not fi ll a prescription. 
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OFF-LABEL PRESCRIPTION RATE OF ANTIDEPRESSANTS AMONG OFFICE BASED PHYSICIAN AND HOSPITAL OUTPATIENT PRACTICES DURING 2003-2005
Panchal JM J , Dhing CW St. John's University, Queens, NY, USA OBJECTIVES: To investigate the off-label prescribing rates of antidepressants among offi ce-based physicians and hospital outpatient department clinics during [2003] [2004] [2005] .
METHODS:
The National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) were used as data sources. Patients who received an antidepressant during the study period were included in the study. Corresponding diagnosis were analyzed to identify off-label prescribing based on Physician Desk Reference and Micromedex. Binary Logistic Regression Analysis was used to predict off-label use on the basis of patient's demographic characteristics and payment methods. Microsoft Access and SPSS 14 were used to analyze the data. RESULTS: From 2003 to 2005, a total of 172,489 patient records were collected, of which, 12,251 patient records were included in the study. A total of 7,068 (57.6%) out of 12,251 antidepressant prescriptions were identifi ed as off-label prescriptions in the 3 years. There were 21 different antidepressants were identifi ed in the databases. Amitriptyline HCl, a TCA/SNRI, had the highest off-label prescription rate among all the antidepressants. According to patient demographics characteristics, the odds of receiving antidepressants off-label were found to be increased with age, elderly adult patients are 2 to 4 times (OR 3.241, 95% CI 2.727-3.852) more likely to get an off-label prescription of antidepressants than children/adolescents. Whites were considered 1.2 times more likely to receive an off-label prescription of antidepressant than non-whites (OR 1.218, 95% CI 1.090-1.361) and 71.7 % Medicare patients were received off-label antidepressant prescription. CONCLUSIONS: Off-label prescribing of antidepressants is highly prevalent, especially in TCA/SNRI class of antidepressants. White elderly adults were more likely to get off-label prescriptions than non-whites adults. Future studies are required to address the questions of legal, clinical and economic aspects of off-label prescribing of antidepressants.
PMH72 IMPACT OF PHARMACY BENEFIT DESIGN ON ANTI-PSYCHOTIC MEDICATION ADHERENCE AND DISCONTINUATION
Knoth RL 1 , Chen CC 1 , Kim E 1 , Zeng F 2 , Patel BV 2 , Leslie S 2 , Tran QV 3 , Pikalov A 3 1 Bristol-Myers Squibb, Plainsboro, NJ, USA, 2 MedImpact Healthcare Systems, Inc., San Diego, CA, USA, 3 Otsuka America Pharmaceutical, Inc, Rockville, MD, USA OBJECTIVES: The study compared medication adherence and time to discontinuation in patients newly initiated on a second generation anti-psychotic (SGA) in health plans with either open or restricted access to antipsychotic medications. Restricted access included preferred formularies, prior authorization, and electronic step-therapy edits. METHODS: A retrospective analysis was performed using claims from a large pharmacy benefi t management company. The company provides pharmacy benefi ts for health plans with a variety of open versus restricted pharmacy benefi t designs. Continuously enrolled commercially insured patients newly initiating atypical antipsychotic therapy between January 1, 2004 and February 28, 2007 were identifi ed and followed for 13 months or until index medication discontinuation. Adherence, defi ned by medication possession ratio (MPR), was calculated as the ratio of total days' supply of medication to total days to discontinuation or end of the follow-up period. Patients with a calculated MPR 80% were defi ned as adherent. Discontinuation was defi ned as a gap of 30 days, switch, or add-on of another antipsychotic. Regression models were used to compare adherence and discontinuation in patients with open vs. restricted access while controlling for gender, copayment, index dosage, and co-morbidity. RESULTS: A total of 8128 patients were included in the study. Of these, 7226 (88.9%) were from health plans with no SGA restrictions. The results showed that patients with open access were signifi cantly more likely to be adherent (OR 1.38, 95% CI: 1.14-1.66), and signifi cantly less likely to discontinue (OR 0.88, 95% CI: 0.81-0.95), than patients with restricted access. CONCLUSIONS: Patients in health plans with restricted access to SGAs were less likely to be adherent and more likely to discontinue when compared to patients with open access to these medications. Since low adherence to SGAs is associated with increased likelihood of inpatient hospitalization, restricted access to antipsychotics may ultimately result in poor patient outcomes and higher overall health care costs.
